GS

DRUG2 trials

Sponsors

Zhejiang University, Kochi University

Conditions

Chemotherapeutic ToxicityChemotherapy EffectPancreatic AdenocarcinomaPancreatic Cancer

Phase 2

Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP

RecruitingNCT05268692

Kochi UniversityPancreatic Adenocarcinoma

Start: 2019-01-01End: 2030-12-31Target: 500Updated: 2022-03-07

Unknown Phase

GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients

CompletedNCT03869294

Zhejiang UniversityChemotherapeutic Toxicity, Chemotherapy Effect, Pancreatic Cancer

Start: 2014-01-01End: 2017-12-31Updated: 2020-03-04